Influenza Hemagglutinin (HA) peptide is a synthetic peptide that corresponds to amino acids 98-106 of the human influenza virus hemagglutinin. The HA Peptide is used for competing out the anti-HA antibody binding to HA-tagged fusion proteins in immunoassays. attaching the virus to cell receptors and for initiating infection.
CAT No: R1854
CAS No: 92000-76-5
Synonyms/Alias: HA Peptide;92000-76-5;Influenza Hemagglutinin (HA) Peptide;(3S)-3-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-carboxypropanoyl]amino]-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-4-[[(2S)-1-[[(1S)-1-carboxyethyl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-4-oxobutanoic acid;HA tag peptide;hemagglutinin tag;HA tag;HA-tag;hemagglutinin peptide;YPYDVPDYA;Tyr-Pro-Tyr-Asp-Val-Pro-Asp-Tyr-Ala;hemagglutinin (HA) tag;hemagglutinin (HA) peptide;CHEBI:80171;EX-A8013H;DTXSID00437019;HVLSXIKZNLPZJJ-TXZCQADKSA-N;AKOS040763949;Influenza Hemagglutinin (HA) Peptide?;DA-74485;H-Tyr-Pro-Tyr-Asp-Val-Pro-Asp-Tyr-Ala-OH;A12940;Influenza Hemagglutinin (HA) Peptide, >=97% (HPLC);L-Tyr-L-Pro-L-Tyr-L-Asp-L-Val-L-Pro-L-Asp-L-Tyr-L-Ala;H-L-Tyr-L-Pro-L-Tyr-L-Asp-L-Val-L-Pro-L-Asp-L-Tyr-L-Ala-OH;(3S)-3-{[(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-AMINO-3-(4-HYDROXYPHENYL)PROPANOYL]PYRROLIDIN-2-YL]FORMAMIDO}-3-(4-HYDROXYPHENYL)PROPANAMIDO]-3-CARBOXYPROPANAMIDO]-3-METHYLBUTANOYL]PYRROLIDIN-2-YL]FORMAMIDO}-3-{[(1S)-1-{[(1S)-1-CARBOXYETHYL]CARBAMOYL}-2-(4-HYDROXYPHENYL)ETHYL]CARBAMOYL}PROPANOIC ACID;L-tyrosyl-L-prolyl-L-tyrosyl-L-alpha-aspartyl-L-valyl-L-prolyl-L-alpha-aspartyl-L-tyrosyl-L-alanine;
Chemical Name: (3S)-3-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-carboxypropanoyl]amino]-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-4-[[(2S)-1-[[(1S)-1-carboxyethyl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-4-oxobutanoic acid
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C53H67N9O17 |
M.W/Mr. | 1102.1 |
Sequence | One Letter Code:YPYDVPDYA Three Letter Code:H-Tyr-Pro-Tyr-Asp-Val-Pro-Asp-Tyr-Ala-OH |
Application | Suitable for use in immunoblotting and when used to elute HA-tagged fusion proteins from an affinity column of Monoclonal Anti-HA agarose. |
Purity | ≥97% (HPLC) |
Long-term Storage Conditions | H2O : 50 mg/mL (45.37 mM; Need ultrasonic) |
Shipping Condition | Wet ice in continental US; may vary elsewhere |
InChI | InChI=1S/C53H67N9O17/c1-27(2)44(52(77)62-21-5-7-41(62)50(75)59-38(25-42(66)67)47(72)56-36(45(70)55-28(3)53(78)79)23-30-10-16-33(64)17-11-30)60-48(73)39(26-43(68)69)57-46(71)37(24-31-12-18-34(65)19-13-31)58-49(74)40-6-4-20-61(40)51(76)35(54)22-29-8-14-32(63)15-9-29/h8-19,27-28,35-41,44,63-65H,4-7,20-26,54H2,1-3H3,(H,55,70)(H,56,72)(H,57,71)(H,58,74)(H,59,75)(H,60,73)(H,66,67)(H,68,69)(H,78,79)/t28-,35-,36-,37-,38-,39-,40-,41-,44-/m0/s1 |
InChI Key | HVLSXIKZNLPZJJ-TXZCQADKSA-N |
Canonical SMILES | CC(C)C(C(=O)N1CCCC1C(=O)NC(CC(=O)O)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(C)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)C4CCCN4C(=O)C(CC5=CC=C(C=C5)O)N |
Isomeric SMILES | C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CC5=CC=C(C=C5)O)N |
2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
5. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.